AI assistant
GlaxoSmithKline PLC Remuneration Information 2021
5262_def-14a_2021-05-18_fbfbb305-dd16-4135-960a-50474f435ca1.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 0302Z
GlaxoSmithKline PLC
18 May 2021
BLOCK LISTING SIX MONTHLY RETURN
Date: 18 May 2021
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan | |||
| Period of return: | From: | 1 November 2020 | To: | 30 April 2021 |
| Balance of unallotted securities under scheme(s) from previous return: | 0 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 300,000 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 264,481 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 35,519 |
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | GlaxoSmithKline plc Share Save Plan 2012 | |||
| Period of return: | From: | 1 November 2020 | To: | 30 April 2021 |
| Balance of unallotted securities under scheme(s) from previous return: | 1,277,629 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 360,000 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 1,255,163 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 382,466 |
The following GlaxoSmithKline plc Employee Share Schemes have expired and therefore will no longer be included in GlaxoSmithKline plc's Block Listing Six Monthly Returns:
· GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan
· GlaxoSmithKline 2009 Share Option Plan - Ordinary Shares
· GlaxoSmithKline 2009 Share Option Plan - ADS
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BLRDZGMKZRKGMZM